Cytokinetics, Incorporated (CYTK) Revenue 2016–2025
Cytokinetics, Incorporated (CYTK) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$88.0MFY2025 · since FY2016: $106.4M → $88.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $88.0M | +376.6% |
| FY2024 | $18.5M | +145.3% |
| FY2023 | $7.5M | -92.0% |
| FY2022 | $94.6M | +34.3% |
| FY2021 | $70.4M | +26.2% |
| FY2020 | $55.8M | +107.8% |
| FY2019 | $26.9M | -14.7% |
| FY2018 | $31.5M | +135.6% |
| FY2017 | $13.4M | -87.4% |
| FY2016 | $106.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice